VistaGen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · IEX Real-Time Price · USD
5.28
+0.71 (15.54%)
Mar 28, 2024, 4:00 PM EDT - Market closed
VistaGen Therapeutics Market Cap
VistaGen Therapeutics has a market cap or net worth of $122.42 million as of March 28, 2024. Its market cap has increased by 317.83% in one year.
Market Cap
122.42M
Enterprise Value
-1.88M
1-Year Change
317.83%
Ranking
Category
Stock Price
$5.28
Market Cap Chart
Since May 11, 2016, VistaGen Therapeutics's market cap has increased from $9.30M to $122.42M, an increase of 1,216.39%. That is a compound annual growth rate of 38.68%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 123.50M | 5.02% |
Mar 26, 2024 | 117.60M | 1.64% |
Mar 25, 2024 | 115.70M | 2.66% |
Mar 22, 2024 | 112.70M | -1.05% |
Mar 21, 2024 | 113.90M | 1.06% |
Mar 20, 2024 | 112.70M | 0.45% |
Mar 19, 2024 | 112.20M | 2.28% |
Mar 18, 2024 | 109.70M | 0.18% |
Mar 15, 2024 | 109.50M | 3.40% |
Mar 14, 2024 | 105.90M | -6.70% |
Mar 13, 2024 | 113.50M | 2.71% |
Mar 12, 2024 | 110.50M | -1.95% |
Mar 11, 2024 | 112.70M | -0.97% |
Mar 8, 2024 | 113.80M | -0.61% |
Mar 7, 2024 | 114.50M | -4.34% |
Mar 6, 2024 | 119.70M | -1.32% |
Mar 5, 2024 | 121.30M | -7.48% |
Mar 4, 2024 | 131.10M | -4.31% |
Mar 1, 2024 | 137.00M | -0.80% |
Feb 29, 2024 | 138.10M | -1.92% |
Feb 28, 2024 | 140.80M | -1.54% |
Feb 27, 2024 | 143.00M | 4.92% |
Feb 26, 2024 | 136.30M | 2.10% |
Feb 23, 2024 | 133.50M | 0.38% |
Feb 22, 2024 | 133.00M | 2.23% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Genetron Holdings | 127.13M |
Seer, Inc. | 125.34M |
Kinnate Biopharma | 125.23M |
The Oncology Institute | 124.64M |
Zentek | 123.00M |
Clearside Biomedical | 119.55M |
Seres Therapeutics | 119.07M |
Cardiol Therapeutics | 118.51M |